| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/11/2013 | CN102323414B Phenobarbital homogeneous-phase enzyme immunoassay reagent kit and preparation method thereof |
| 09/11/2013 | CN102264393B Anti-hcv monoclonal antibody as a medicament for the therapeutic treatment and prevention of hcv infections |
| 09/11/2013 | CN102010468B Toxoplasma circulating antigen double antibody sandwich ELISA (Enzyme-Linked Immuno Sorbent Assay) detection method |
| 09/11/2013 | CN101961488B Method for preparing serum for resisting Muscovy duck parvovrius |
| 09/11/2013 | CN101525385B Screening and preparation method and application for antibody medicament for malignant lymphoma and autoimmune diseases |
| 09/10/2013 | US8530629 Lowered affinity antibodies and uses therefor |
| 09/10/2013 | US8530628 Diagnosis and treatment of diseased and damaged tissue |
| 09/10/2013 | US8530627 FcγRIIB specific antibodies and methods of use thereof |
| 09/10/2013 | US8530421 Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis |
| 09/10/2013 | US8530417 Y-shaped polyethylene glycol modified G-CSF, the preparation and use thereof |
| 09/10/2013 | US8530414 Antibodies to PCSK9 and uses thereof |
| 09/10/2013 | US8530408 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8530190 Disulfide crosslinked glycoprotein hormone analogs, and their preparation and use |
| 09/10/2013 | US8530189 Sustained drug delivery system |
| 09/10/2013 | US8530177 Chloral hydrate detection |
| 09/10/2013 | US8530173 Methods for treatment of cardiovascular disease |
| 09/10/2013 | US8529943 Angiopoietin derived peptides |
| 09/10/2013 | US8529910 Enterococcus antigens |
| 09/10/2013 | US8529904 Antigenic peptide comprising sequenc simimlarity to wilm's tumor-1 gene a nd gata-1 transcription factor for use as targeting tools in treatment of cell proliferative disorders; tissue targeted therapy |
| 09/10/2013 | US8529902 for promoting proliferation and/or differentiation of B cells involved in cancers and autoimmune disorders; animal models; genetic engineering |
| 09/10/2013 | US8529898 Activatable binding polypeptides and methods of identification and use thereof |
| 09/10/2013 | US8529895 Method for suppressing the development of graft-versus-host-disease by administering interleukin 6 receptor antibodies |
| 09/10/2013 | US8529894 Methods of reducing inflammation in cardiomyopathy |
| 09/10/2013 | US8529893 Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors |
| 09/10/2013 | US8529891 Inhibitors of extracellular HSP90 |
| 09/10/2013 | CA2693296C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/10/2013 | CA2608058C Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 09/10/2013 | CA2573192C Variant fc regions |
| 09/10/2013 | CA2492498C Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/10/2013 | CA2458627C Human cdr-grafted antibody and antibody fragment thereof |
| 09/10/2013 | CA2456247C Use of il-18 inhibitors in hypersensitivity disorders |
| 09/10/2013 | CA2433394C Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 09/10/2013 | CA2376693C Immunological control of .beta.-amyloid levels in vivo |
| 09/10/2013 | CA2331789C Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 09/10/2013 | CA2272245C Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 09/08/2013 | CA2770773A1 Novel method for analyzing circulating tumor cells of a patient for the presence of metastasis-initiating cells |
| 09/06/2013 | WO2013131019A1 Iaspp phosphorylation and metastatic potential |
| 09/06/2013 | WO2013130981A1 Human antibodies to clostridium difficile toxins |
| 09/06/2013 | WO2013130959A1 Methods for the treatment of b cell-mediated inflammatory diseases |
| 09/06/2013 | WO2013130826A2 Igg stimulated remyelination of peripheral nerves |
| 09/06/2013 | WO2013130814A1 Novel prodrug containing molecule compostions and their uses |
| 09/06/2013 | WO2013130565A1 Neutralizing antibody for epstein barr virus associated disease |
| 09/06/2013 | WO2013130462A1 Antibody production methods |
| 09/06/2013 | WO2013130393A1 Aav-directed persistent expression of an anti-nicotine antibody gene for smoking cessation |
| 09/06/2013 | WO2013130381A1 Cx3cr1-binding polypeptides |
| 09/06/2013 | WO2013130078A1 Antibodies to matrix metalloproteinase 9 |
| 09/06/2013 | WO2013128441A1 Methods and compositions for treating psc(primary sclerosing cholangitis) or pbc (primary biliary cirrhosis) with anti-cd3 immune molecule therapy |
| 09/06/2013 | WO2013128204A1 Method of identifying vdj recombination products |
| 09/06/2013 | WO2013128194A1 Immunotherapeutic molecules and uses |
| 09/06/2013 | WO2013128031A1 Pseudomonas aeruginosa pcrv binding single variable domain antibodies |
| 09/06/2013 | WO2013128027A1 Long life polypeptide binding molecules |
| 09/06/2013 | WO2013126962A1 Therapeutic and diagnostic agents |
| 09/06/2013 | WO2013082282A9 Anti-il-1beta (interleukin-1beta) antibody-based prophylactic therapy to prevent complications leading to vaso-occlusion in sickle cell disease. |
| 09/06/2013 | WO2013035345A3 Dengue-virus serotype neutralizing antibodies |
| 09/06/2013 | WO2013003625A3 Antibodies to adp-ribosyl cyclase 2 |
| 09/05/2013 | US20130232589 Ovr110 antibody compositions and methods of use |
| 09/05/2013 | US20130231466 Methods for detecting th1 cells |
| 09/05/2013 | US20130231465 Novel antibody to a carbonic anhydrase |
| 09/05/2013 | US20130231463 Cell Display Of Antibody Libraries |
| 09/05/2013 | US20130231462 Anti-immune complex antibodies |
| 09/05/2013 | US20130231280 Novel Peptide Involved in Energy Homeostasis |
| 09/05/2013 | US20130230899 Therapeutic agent for arteriosclerosis or arteriosclerotic disease, and diagnostic agent for arteriosclerosis or arteriosclerotic disease |
| 09/05/2013 | US20130230886 Antibodies to TNF Alpha |
| 09/05/2013 | US20130230869 Antibody against colorectal cancer marker |
| 09/05/2013 | US20130230861 Method for detection of idiopathic interstitial pneumonia |
| 09/05/2013 | US20130230855 Monocyte-derived Nucleic Acids and Related Compositions and Methods |
| 09/05/2013 | US20130230600 Therapeutic agent |
| 09/05/2013 | US20130230584 Treating bladder tumor cells using fibronectin attachment protein as a target |
| 09/05/2013 | US20130230541 Anti-igf antibodies |
| 09/05/2013 | US20130230540 Compositions monovalent for cd28 binding and methods of use |
| 09/05/2013 | US20130230538 Method of treating a patient having an autoimmune disorder by administering baffr polypeptide |
| 09/05/2013 | US20130230537 Clostridium difficile-specific antibodies and uses thereof |
| 09/05/2013 | US20130230536 Antagonistic human light-specific human monoclonal antibodies |
| 09/05/2013 | US20130230534 Interferon Receptor 1 Antibodies And Their Uses |
| 09/05/2013 | US20130230531 Human Antibodies to Clostridium difficile Toxins |
| 09/05/2013 | US20130230530 Human antibodies that bind cd22 and uses thereof |
| 09/05/2013 | US20130230529 Novel paramyxovirus and uses thereof |
| 09/05/2013 | US20130230527 Emp2 antibodies and their therapeutic uses |
| 09/05/2013 | US20130230526 Klebsiella antigens |
| 09/05/2013 | US20130230525 Protein complexes for antigen binding and methods of use |
| 09/05/2013 | US20130230524 Protein Involved in Ovarian Cancer |
| 09/05/2013 | US20130230523 Methods for detecting th1 cells |
| 09/05/2013 | US20130230522 Complement Pathway Inhibitors Binding To C5 and C5A Without Preventing The Formation of C5B |
| 09/05/2013 | US20130230521 Tumor-Targeting Monoclonal Antibodies to FZD10 and Uses Thereof |
| 09/05/2013 | US20130230519 Anti-serum albumin binding variants |
| 09/05/2013 | US20130230517 Engineered antibody-interferon mutant fusion molecules |
| 09/05/2013 | US20130230516 Targeted cryptosporidium biocides |
| 09/05/2013 | US20130230515 Myostatin binding agents |
| 09/05/2013 | US20130230513 Assay Method for Alzheimer's Disease |
| 09/05/2013 | US20130230507 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
| 09/04/2013 | EP2634196A1 Anti-mesothelin antibodies and uses therefor |
| 09/04/2013 | EP2634195A1 Separation of living untouched neurons |
| 09/04/2013 | EP2634194A1 Anti-cdh3 antibody having high internalization capacity |
| 09/04/2013 | EP2633317A1 Treatment of gastrointestinal inflammation and psoriasis a |
| 09/04/2013 | EP2632956A1 Methods of generating antibodies to metalloenzymes |
| 09/04/2013 | EP2632955A1 Antibodies which bind soluble t-cell receptor ligands |
| 09/04/2013 | EP2632954A1 Means and methods for treating dlbcl |
| 09/04/2013 | EP2632953A1 Antibodies for the treatment of hiv |
| 09/04/2013 | EP2632952A2 Anti-sod1 antibodies and uses thereof |